Research

Prospective monitoring improves outcomes of primary total hip replacement: a cohort study

Philipp N Streubel^1,2 , Marcela Pachón¹ , Carlos A Kerguelén³ , José Navas^1,2 , Julio Portocarrero³ , Rodrigo F Pesantez¹ , Gamal Zayed¹ , Germán Carrillo¹ and Adolfo M Llinás^1,2

¹  Departamento de Ortopedia y Traumatología, Fundación Santa Fe de Bogotá/Universidad de los Andes, Calle 119 No 9-33, Bogotá, Colombia

²  División de Investigación, Banco de Huesos y Tejidos, Fundación Cosme y Damián, Calle 119A No 7-91, Bogotá, Colombia

³  Centro de Gestión Hospitalaria, Carrera 11A No 94-76, Of. 201, Bogotá, Colombia

author email corresponding author email

Patient Safety in Surgery 2009, 3:7doi:10.1186/1754-9493-3-7

Published:	14 April 2009

Abstract

Background

Over the past decade several studies have questioned current standards of patient safety in health care delivery. In response, our institution started a clinical pathway for total hip replacement in 1996. Prospective monitoring with regular feedback sessions to the individuals involved in patient care did however not start until 2003. The present study evaluates the effect of prospective monitoring on outcomes of total hip replacement.

Methods

Clinical records of patients undergoing primary elective total hip replacement between 1997 and 2004 were reviewed. Data on adverse events as well as adherence to protocols for venous thromboembolism prophylaxis were extracted retrospectively for the period 1997 to 2001 and prospectively from 2003 to 2004. Results were compared and analyzed in order to establish possible improvement in outcomes. Data was analyzed with Chi-square or Fisher's Exact test for categorical variables and Student's t-test for continuous variables. Alpha was set as less than 5% and analysis was performed with Stata 9.0 for Macintosh.

Results

Two-hundred and eighty-three patients were included from 1997 to 2001, and 62 from 2003 to 2004. Mean age, male to female ratio and initial diagnosis were similar in both groups. At least one adverse event occurred in 45% of patients in 1997–2001 and in 21% in 2003–2004 (p < 0.001). In-hospital hip dislocations occurred in 6% and 0% (p = 0.05), oliguria in 19% and 5% (p = 0.007), SSI and VTE in 3% and 0% (p = 0.37), adverse drug reactions in 11% and 13% (p = 0.66) and non-adherence to VTE prophylaxis protocols in 15% and 2% of cases respectively (p = 0.002).

Conclusion

Overall rate of adverse events as well as in-hospital hip dislocations, oliguria and non-adherence to VTE prophylaxis protocols were significantly reduced during the second period. We conclude that clinical pathways alone are insufficient to improve patient safety and require prospective monitoring and continuous feedback to health care providers in order to achieve the desired effect.